Inhibrx Biosciences Growth Metrics (2023-2025) | INBX

Growth Metrics Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -2.31M-4.45M15.88M
EBITDA Margin (QoQ) (Quarter) 9.93M3.31M
EBIT Margin Growth (1y) (Quarter) -2.31M-4.45M15.88M
EBIT Margin (QoQ) (Quarter) 9.93M3.31M
EBT Margin Growth (1y) (Quarter) 201.48M-4.22M-186.02M
EBT Margin (QoQ) (Quarter) 11.33M3.79M
Enterprise Value Growth (1y) (Quarter) 45.09%17.76%22.01%18.61%
Enterprise Value (QoQ) (Quarter) 13.47%22.26%-41.89%13.83%17.94%18.88%
FCF Margin Growth (1y) (Quarter) -3.91M5.50M
FCF Margin (QoQ) (Quarter) 4.29M
Interest Coverage Ratio Growth (1y) (Quarter) -469.77%-134.75%48.95%89.43%78.84%
Interest Coverage Ratio (QoQ) (Quarter) -7.54%-90.53%15.25%-228.13%81.57%32.05%-34.33%-25.79%
Net Margin Growth (1y) (Quarter) 201.49M-4.22M-186.02M
Net Margin (QoQ) (Quarter) 11.33M3.79M
Operating Margin Growth (1y) (Quarter) -2.31M-4.45M15.88M
Operating Margin (QoQ) (Quarter) 9.93M3.31M
Return on Assets Growth (1y) (Quarter) -8.00-9.00
Return on Assets (QoQ) (Quarter) 2.000.00M-9.000.00M0.00M
Return on Capital Employed Growth (1y) (Quarter) 0.01M0.01M
Return on Capital Employed (QoQ) (Quarter) -0.00M0.00M0.01M-836.00-835.00
Return on Sales Growth (1y) (Quarter) 0.02M0.00M-422.00-0.02M-998.00379.00
Return on Sales (QoQ) (Quarter) 0.00M379.00-0.02M-0.00M-89.0011.00